GB0010327D0 - Peptides - Google Patents

Peptides

Info

Publication number
GB0010327D0
GB0010327D0 GBGB0010327.5A GB0010327A GB0010327D0 GB 0010327 D0 GB0010327 D0 GB 0010327D0 GB 0010327 A GB0010327 A GB 0010327A GB 0010327 D0 GB0010327 D0 GB 0010327D0
Authority
GB
United Kingdom
Prior art keywords
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0010327.5A
Other versions
GB2361701A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norsk Hydro ASA
Original Assignee
Norsk Hydro ASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro ASA filed Critical Norsk Hydro ASA
Priority to GB0010327A priority Critical patent/GB2361701A/en
Publication of GB0010327D0 publication Critical patent/GB0010327D0/en
Priority to PCT/NO2001/000180 priority patent/WO2001083689A2/en
Priority to AU2001262806A priority patent/AU2001262806A1/en
Publication of GB2361701A publication Critical patent/GB2361701A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/1252DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45Transferases (2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB0010327A 2000-04-28 2000-04-28 DNA polymerase delta mutants Withdrawn GB2361701A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0010327A GB2361701A (en) 2000-04-28 2000-04-28 DNA polymerase delta mutants
PCT/NO2001/000180 WO2001083689A2 (en) 2000-04-28 2001-04-27 PEPTIDES FROM FRAMESHIFT MUTATED DNA POLYMERASE δ GENE
AU2001262806A AU2001262806A1 (en) 2000-04-28 2001-04-27 Peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0010327A GB2361701A (en) 2000-04-28 2000-04-28 DNA polymerase delta mutants

Publications (2)

Publication Number Publication Date
GB0010327D0 true GB0010327D0 (en) 2000-06-14
GB2361701A GB2361701A (en) 2001-10-31

Family

ID=9890650

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0010327A Withdrawn GB2361701A (en) 2000-04-28 2000-04-28 DNA polymerase delta mutants

Country Status (3)

Country Link
AU (1) AU2001262806A1 (en)
GB (1) GB2361701A (en)
WO (1) WO2001083689A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728523A (en) * 1994-12-30 1998-03-17 The Johns Hopkins University Polymerase delta mutations in colorectal tumors with replication errors
AU7142796A (en) * 1995-10-02 1997-04-28 Erasmus University Rotterdam Diagnosis method and reagents
NO315238B1 (en) * 1998-05-08 2003-08-04 Gemvax As Peptides derived from reading frame shift mutations in the TBF <beta> II or BAX gene, and pharmaceutical compositions containing them, nucleic acid sequences encoding such peptides, plasmids, and virus vector-encompassing such nucleic acid

Also Published As

Publication number Publication date
AU2001262806A1 (en) 2001-11-12
GB2361701A (en) 2001-10-31
WO2001083689A2 (en) 2001-11-08
WO2001083689A3 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
GB0014870D0 (en) Peptides
GB0001704D0 (en) Protein
GB0100196D0 (en) Peptides
GB0029777D0 (en) Peptides
GB0011185D0 (en) Protein
AU6268901A (en) Oligopeptides
GB0015761D0 (en) Polypeptide
GB0124032D0 (en) Protein
EP1147130A4 (en) Alpha-conotoxin peptides
GB0109438D0 (en) Peptides
GB0001825D0 (en) Peptides
GB0121215D0 (en) Polypeptide
GB0007263D0 (en) Peptides
GB0009181D0 (en) Protein
EP1179592A4 (en) Proteins nectin-3
EP1323731A4 (en) Novel peptides
IL150774A0 (en) Apoptin-associating protein
EP1323734A4 (en) Irap-binding protein
GB0021475D0 (en) Anti-aniogenic peptides
GB0007264D0 (en) Peptides
GB0001826D0 (en) Peptides
GB0010327D0 (en) Peptides
GB0013239D0 (en) Polypeptide
GB0119929D0 (en) Protein
GB0008549D0 (en) Protein

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)